Skip to main content
SHENZHEN NEPTUNUS BIOENGINEERING CO.,LTD logo

SHENZHEN NEPTUNUS BIOENGINEERING CO.,LTD — Investor Relations & Filings

Ticker · 000078 ISIN · CNE000000X95 LEI · 300300J4GCOV7CYQTB51 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,616 across all filing types
Latest filing 2024-04-29 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 000078

About SHENZHEN NEPTUNUS BIOENGINEERING CO.,LTD

https://www.neptunusbio.com

Shenzhen Neptunus Bioengineering Co., Ltd. is a comprehensive healthcare enterprise focused on the research, development, manufacturing, and distribution of pharmaceutical products. The company operates across the entire industry value chain, including the production of chemical drugs, biological preparations, and traditional Chinese medicines. Its portfolio extends to medical devices and health supplements. A significant component of its operations involves a large-scale pharmaceutical distribution network and a nationwide retail pharmacy chain. The company emphasizes innovation in biotechnology and maintains modern production facilities to support its diverse product lines. By integrating R&D with a robust logistics and retail infrastructure, it provides a wide range of healthcare solutions to medical institutions and consumers.

Recent filings

Filing Released Lang Actions
审计委员会对会计师事务所2023年度履职情况评估报告和履行监督职责情况报告
Audit Report / Information Classification · 95% confidence The document is an evaluation report by the Audit Committee on the performance of the external audit firm for the fiscal year 2023. It discusses the audit firm's qualifications, independence, and the committee's supervision of the audit process. It does not contain actual financial statements or detailed financial data but rather focuses on the audit firm's oversight and performance evaluation. This fits the definition of an Audit Report / Information (AR), which includes standalone audit reports and results of internal or regulatory oversight related to audits, excluding full annual reports. The document length is 1665 characters, which is short but contains substantive content about audit oversight, not just an announcement or certification. Therefore, the appropriate classification is AR with high confidence. FY 2023
2024-04-29 Chinese
2023年度监事会工作报告
Management Reports Classification · 95% confidence The document is titled '2023 年度监事会工作报告' which translates to '2023 Supervisory Board Work Report' of Shenzhen Haier Bioengineering Co., Ltd. It details the supervisory board's activities, oversight of financial reports, compliance with laws and regulations, and plans for 2024. It references the review of annual and quarterly reports but does not contain the financial statements themselves. The document is a report on the supervisory board's work and oversight rather than a full annual report or interim financial report. It is not an announcement or certification but a detailed management oversight report. Therefore, it fits best under Management Reports (MDA).
2024-04-29 Chinese
2023年度独立董事述职报告（张巍松）
Board/Management Information Classification · 95% confidence The document is titled '2023 年度独立董事述职报告（张巍松）' which translates to '2023 Annual Independent Director's Work Report (Zhang Weisong)'. It is a detailed report by an independent director about his duties, attendance at board meetings, committee work, supervision of company affairs, and overall evaluation for the year 2023. The content focuses on the director's responsibilities, governance, internal control, and compliance with laws and company rules. It does not contain financial statements or audit results but is a formal report on the director's management and governance role. This fits the category of Board/Management Information (MANG), which covers announcements or reports about changes or activities of the board or senior management. The document length is under 5,000 characters, but it is a substantive report, not a mere announcement of a report publication. Therefore, the best classification is MANG with high confidence.
2024-04-29 Chinese
2023年度内部控制自我评价报告
Audit Report / Information Classification · 95% confidence The document is titled '2023 年度内部控制自我评价报告' which translates to '2023 Annual Internal Control Self-Evaluation Report'. It is a detailed report on the company's internal control evaluation for the year ending December 31, 2023. The content includes descriptions of internal control frameworks, evaluation conclusions, defect identification and rectification, and compliance with regulatory requirements. It is a comprehensive report focused on internal control effectiveness rather than a general annual report or financial statement. It does not appear to be an announcement or a brief summary but a full report with substantive content. This fits the category of an Audit Report / Information (AR), which includes standalone audit reports and internal control evaluations. Therefore, the appropriate classification is AR with high confidence. FY 2023
2024-04-29 Chinese
第九届董事局第十五次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 15th meeting of the 9th Board of Directors of Shenzhen Haiwang Bioengineering Co., Ltd. It includes voting results on various reports and proposals related to the 2023 annual report, financial statements, profit distribution plan, internal control reports, audit reports, remuneration, and other governance matters. The document references that the full 2023 annual report and other detailed reports are published elsewhere (on the official disclosure platform and newspapers). The document is not the annual report itself but a formal announcement of board meeting decisions and approvals related to the annual report and other corporate governance matters. It also includes voting results and procedural details of the board meeting. This fits the definition of Board/Management Information (MANG) as it announces board meeting resolutions and management decisions. The document length is 3519 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, the correct classification is MANG with high confidence.
2024-04-29 Chinese
深圳市海王生物工程股份有限公司2023年年度报告摘要
Annual Report Classification · 100% confidence The document is titled as the "2023 Annual Report Summary" of Shenzhen Haier Bioengineering Co., Ltd. It contains detailed financial data for the year 2023, including revenue, net profit, quarterly financial data, business overview, research and development activities, patent information, shareholder structure, and important corporate events. The document is comprehensive and includes substantive financial statements and analysis for the full fiscal year 2023. It is not a brief announcement or a certification letter but a detailed report summarizing the company's annual performance. Therefore, it fits the definition of an Annual Report (10-K). FY 2023
2024-04-29 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.